New Symptoms, Conditions May Develop After Positive Test for SARS-CoV-2
Among hospitalized patients aged 20 years or older, prevalence of new fatigue, T2DM up for those with positive versus negative SARS-CoV-2 result
Prior SARS-CoV-2 Infection Less Protective Against Omicron Variant
Effectiveness of previous infection in prevention of reinfection about 90 percent for alpha, beta, delta variants; 56 percent for omicron variant
Physician’s Briefing Weekly Coronavirus Roundup
FDA Postpones Decision on Pfizer COVID-19 Vaccine for Under 5s
Step was taken after Pfizer notified the agency it would like to wait until data are available on a three-dose regimen
FDA Approves New Antibody Drug to Fight Omicron Variant
Emergency use authorization for bebtelovimab is for the treatment of mild-to-moderate COVID-19
Mandatory COVID-19 Tests Lifted for Vaccinated Travelers to Britain
Those who have had at least two doses of vaccine now only need to fill out a passenger locator form before arrival
U.S. Buys 600,000 Doses of New COVID-19 Treatment Still Awaiting FDA Approval
New drug will be distributed to states for free if it receives emergency use authorization from the FDA
AACR Addresses Impact of COVID-19 on Cancer Care Continuum
Issues include increased burden of COVID-19 in patients with cancer, lessons from COVID-19 with potential to improve cancer care
Test-to-Stay Program Safe for Facilitating In-Person Learning
Per-person positivity rate was 2.9 percent; maximum of 497,150 days of in-person school saved with daily testing
~30 Percent of Seniors Have Sequelae After Acute SARS-CoV-2
Greatest excess risk seen for respiratory failure, fatigue, hypertension, memory difficulties compared with matched individuals without COVID-19
